INDUSTRY × Cholangiocarcinoma × Clear all
NCT02568267 2026-05-27

STARTRK-2

Hoffmann-La Roche

Phase 2 Active not recruiting
534 enrolled 1 FDA
NCT05461430 2026-04-13

TraveraRTGx

Travera Inc

Completed
72 enrolled